EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of vaccination on antibody level and duration of viral shedding in Omicron patients

Zhen Wan, Jing Han, Deyin Wang, Yonghui Li, Weixiang Zhai, Weikang Zhao, Xiaodong Zhang, Yi Xie

The Journal of Infection in Developing Countries · 2024

DOI: 10.3855/jidc.19160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Zhen Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Haihe Hospital,Tianjin University, Tianjin, 300350, China. Hauptthemen laut MEDLINE: COVID-19, Virus Shedding, Antibodies, Viral, Immunoglobulin G. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We compared the clinical characteristics of vaccinated and non-vaccinated Omicron patients in order to provide a reference for the clinical diagnosis and treatment of coronavirus disease 2019 (COVID-19). Methodology: This study included 360 patients diagnosed with COVID-19. The serum immunoglobulin G (IgG) and serum immunoglobulin M (IgM) antibody levels of the patients and the duration of virus shedding were analyzed according to age, gender, vaccine dose, and the time from the most recent vaccination to the onset of Omicron infection.

Results

Age (OR = 0.974), days from last vaccination to onset ≤ 180 days (OR = 4.409), and booster dose of the vaccine (OR = 4.999) were protective factors associated with patients who were IgG antibody positive. The duration of virus shedding in IgG -antibody-positive patients was 9 (8-11) days; and this was significantly lower than that in IgG-antibody-negative patients, who had virus shedding duration of 10 (8-12) days (p < 0.05).

Conclusions

Booster immunizations could increase IgG-antibody in patients who have already been infected with the Omicron variant and enhance immune protection. In addition, COVID-19 vaccination may shorten the duration of virus shedding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Virus SheddingAntibodies, ViralImmunoglobulin GCOVID-19 VaccinesSARS-CoV-2Immunoglobulin MImmunization, SecondaryHumansFemaleMaleMiddle AgedAdultAgedVaccinationYoung AdultTime FactorsAdolescent

Stichwörter der Autor:innen

COVID-19Omicronantibodyinfectivityvaccination

Substanzen

Antibodies, ViralImmunoglobulin GCOVID-19 VaccinesImmunoglobulin M

Autor:innen und Institutionen

  • Haihe Hospital,Tianjin University, Tianjin, 300350, China.
  • Tianjin University of Finance and Economics, Tianjin, 300221, China.
  • Tianjin University, Tianjin, 300072, China.
  • Tianjin Medical College, Tianjin, 300222, China.

Zitieren

APA

Wan, Z., Han, J., Wang, D., Li, Y., Zhai, W., Zhao, W., Zhang, X., & Xie, Y. (2024). Effects of vaccination on antibody level and duration of viral shedding in Omicron patients. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.19160

Vancouver

Wan Z, Han J, Wang D, Li Y, Zhai W, Zhao W, et al. Effects of vaccination on antibody level and duration of viral shedding in Omicron patients. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.19160

BibTeX
@article{Wan2024,
  author = {Wan, Zhen and Han, Jing and Wang, Deyin and Li, Yonghui and Zhai, Weixiang and Zhao, Weikang and Zhang, Xiaodong and Xie, Yi},
  title = {Effects of vaccination on antibody level and duration of viral shedding in Omicron patients},
  journal = {The Journal of Infection in Developing Countries},
  year = {2024},
  doi = {10.3855/jidc.19160}
}
Kostenlos starten →